A detailed history of Strs Ohio transactions in Evolus, Inc. stock. As of the latest transaction made, Strs Ohio holds 29,300 shares of EOLS stock, worth $319,077. This represents 0.0% of its overall portfolio holdings.

Number of Shares
29,300
Previous 19,600 49.49%
Holding current value
$319,077
Previous $212,000 123.58%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$10.66 - $17.48 $103,402 - $169,556
9,700 Added 49.49%
29,300 $474,000
Q2 2024

Aug 05, 2024

BUY
$10.45 - $13.76 $196,460 - $258,688
18,800 Added 2350.0%
19,600 $212,000
Q1 2024

May 13, 2024

SELL
$9.99 - $14.91 $999 - $1,491
-100 Reduced 11.11%
800 $11,000
Q4 2023

Jan 30, 2024

SELL
$7.6 - $10.53 $130,720 - $181,116
-17,200 Reduced 95.03%
900 $9,000
Q2 2023

Jul 31, 2023

BUY
$7.23 - $10.52 $67,239 - $97,836
9,300 Added 105.68%
18,100 $131,000
Q1 2023

Aug 02, 2023

SELL
$7.81 - $11.05 $72,633 - $102,765
-9,300 Reduced 51.38%
8,800 $74,000
Q1 2023

Apr 27, 2023

SELL
$7.81 - $11.05 $10,934 - $15,470
-1,400 Reduced 13.73%
8,800 $74,000
Q4 2022

Jan 26, 2023

SELL
$6.52 - $8.95 $56,071 - $76,970
-8,600 Reduced 45.74%
10,200 $76,000
Q2 2022

Jul 25, 2022

SELL
$10.22 - $13.94 $522,242 - $712,334
-51,100 Reduced 73.1%
18,800 $218,000
Q1 2022

Apr 21, 2022

SELL
$5.22 - $11.78 $22,968 - $51,832
-4,400 Reduced 5.92%
69,900 $784,000
Q4 2021

Jan 24, 2022

BUY
$5.37 - $8.38 $95,049 - $148,326
17,700 Added 31.27%
74,300 $483,000
Q3 2021

Oct 22, 2021

BUY
$7.36 - $13.67 $152,352 - $282,969
20,700 Added 57.66%
56,600 $431,000
Q2 2021

Jul 26, 2021

BUY
$8.42 - $13.96 $302,278 - $501,164
35,900 New
35,900 $454,000
Q2 2019

Jul 25, 2019

SELL
$13.19 - $28.36 $32,975 - $70,900
-2,500 Closed
0 $0
Q3 2018

Oct 19, 2018

BUY
$17.31 - $29.82 $19,041 - $32,802
1,100 Added 78.57%
2,500 $46,000
Q1 2018

Apr 20, 2018

BUY
$8.34 - $12.5 $11,676 - $17,500
1,400 New
1,400 $12,000

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $611M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.